Mohammed Kazim Panjwani
www.linkedin.com
0000-0002-2305-1164
Sloan Kettering Institute
9 papers found
Refreshing results…
Single-Cell Profiling Reveals a Naive-Memory Relationship between CD56brightand Adaptive Human Natural Killer Cells
Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia
Human Cytomegalovirus Infection Promotes Expansion of a Functionally Superior Cytoplasmic CD3+ NK Cell Subset with a Bcl11b-Regulated T Cell Signature
Human cytomegalovirus expands a CD8 + T cell population with loss of BCL11B expression and gain of NK cell identity
Establishing a model system for evaluating CAR T cell therapy using dogs with spontaneous diffuse large B cell lymphoma
Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas
Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma
750. Anti-Tumor Effects of Anti-CD20 Chimeric Antigen Receptor Therapy in Canine B Cell Lymphoma Patients
Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies
Missing publications? Search for publications with a matching author name.